• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quality of life after coronary revascularization in the elderly.

作者信息

Graham Michelle M, Norris Colleen M, Galbraith P Diane, Knudtson Merril L, Ghali William A

机构信息

Division of Cardiology, Department of Medicine, University of Alberta Hospital, 8, 440-112 Street, Edmonton, Alberta, Canada T6G 2R7.

出版信息

Eur Heart J. 2006 Jul;27(14):1690-8. doi: 10.1093/eurheartj/ehl038. Epub 2006 May 22.

DOI:10.1093/eurheartj/ehl038
PMID:16717072
Abstract

AIMS

To describe health status outcomes at 4 years for a cohort of elderly patients with cardiac disease.

METHODS AND RESULTS

Using the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease, an outcomes initiative capturing all patients undergoing cardiac catheterization in Alberta, Canada, health status was measured using the Seattle Angina Questionnaire (SAQ) and crude and risk-adjusted outcomes were determined and compared for patients treated with percutaneous coronary intervention or coronary artery bypass surgery (CABG) vs. medical therapy. Response rates among surviving, consenting patients were 64.8% for patients <70 years (n=7883), 77.3% for patients aged 70-79 years (n=2940), and 77.7% for patients >or=80 years of age (n=439). For patients aged <70 years, and those aged 70-79 years, for all dimensions of the SAQ, scores were significantly better for patients treated with revascularization procedures than with medical therapy. For patients over the age of 80 years, scores for patients treated with CABG in particular were significantly better, with the exception of exertional capacity. At 3 years, all scores remained stable or improved, and continued to favour revascularization.

CONCLUSION

Elderly patients undergoing revascularization have better health status at 4 years than do those in the same age group who do not undergo revascularization. These findings suggest that age should not deter against revascularization given the combined survival and quality-of-life benefits.

摘要

相似文献

1
Quality of life after coronary revascularization in the elderly.
Eur Heart J. 2006 Jul;27(14):1690-8. doi: 10.1093/eurheartj/ehl038. Epub 2006 May 22.
2
Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.接受心脏手术、经皮冠状动脉介入治疗或药物治疗的冠心病患者与健康相关的生活质量结果。
Can J Cardiol. 2004 Oct;20(12):1259-66.
3
Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery.接受经皮冠状动脉介入治疗与冠状动脉旁路移植术的患者的再狭窄风险和健康状况结果。
Circulation. 2005 Feb 15;111(6):768-73. doi: 10.1161/01.CIR.0000155242.70417.60. Epub 2005 Feb 7.
4
The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.年龄对冠状动脉搭桥手术与支架辅助经皮冠状动脉介入治疗后结局的影响:支架或手术(SoS)试验的一年结果
Am Heart J. 2006 Dec;152(6):1153-60. doi: 10.1016/j.ahj.2006.06.011.
5
Effect of difficulty affording health care on health status after coronary revascularization.支付医疗保健费用困难对冠状动脉血运重建术后健康状况的影响。
Circulation. 2005 May 24;111(20):2572-8. doi: 10.1161/CIRCULATIONAHA.104.474775. Epub 2005 May 9.
6
Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.与经皮冠状动脉介入治疗相比,在大多数多支冠状动脉疾病亚组患者中,外科血管重建术与更好的长期预后相关:来自山间心脏注册研究的结果。
Circulation. 2007 Sep 11;116(11 Suppl):I226-31. doi: 10.1161/CIRCULATIONAHA.106.681346.
7
Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.冠状动脉搭桥术与经皮冠状动脉介入治疗高危患者血运重建的成本效益分析
Circulation. 2006 Sep 19;114(12):1251-7. doi: 10.1161/CIRCULATIONAHA.105.570838. Epub 2006 Sep 11.
8
Quality of life after myocardial revascularization. Effect of increasing age.心肌血运重建术后的生活质量。年龄增长的影响。
J Thorac Cardiovasc Surg. 1992 Jan;103(1):108-15.
9
Comparison of the quality of life after conventional versus off-pump coronary artery bypass surgery.传统冠状动脉搭桥手术与非体外循环冠状动脉搭桥手术后生活质量的比较。
J Card Surg. 2008 Mar-Apr;23(2):120-5. doi: 10.1111/j.1540-8191.2008.00590.x.
10
Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study.多支血管病变糖尿病患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗术后 5 年的生活质量比较:一项注册研究。
Eur Heart J Qual Care Clin Outcomes. 2017 Jul 1;3(3):216-223. doi: 10.1093/ehjqcco/qcw055.

引用本文的文献

1
Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis.冠状动脉疾病中的运动类型与环境、生活质量及心理健康:一项网状Meta分析
Eur Heart J. 2025 Jun 16;46(23):2186-2201. doi: 10.1093/eurheartj/ehae870.
2
Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial.稳定型缺血性心脏病合并 2 型糖尿病老年患者的生活质量:BARI 2D 试验的事后分析。
Am J Cardiol. 2024 Jul 15;223:58-69. doi: 10.1016/j.amjcard.2024.05.016. Epub 2024 May 24.
3
Response shift in coronary artery disease.
冠心病中的反应转移。
Qual Life Res. 2024 Mar;33(3):767-776. doi: 10.1007/s11136-023-03564-1. Epub 2023 Dec 22.
4
Unsupervised item response theory models for assessing sample heterogeneity in patient-reported outcomes measures.用于评估患者报告结局测量中样本异质性的无监督项目反应理论模型。
Qual Life Res. 2024 Mar;33(3):853-864. doi: 10.1007/s11136-023-03560-5. Epub 2023 Dec 21.
5
Revascularization strategies for patients with established chronic coronary syndrome.已确诊慢性冠状动脉综合征患者的血运重建策略。
Eur J Clin Invest. 2022 Aug;52(8):e13787. doi: 10.1111/eci.13787. Epub 2022 Apr 29.
6
Response shift after coronary revascularization.冠状动脉血运重建后的反应转移。
Qual Life Res. 2022 Feb;31(2):437-450. doi: 10.1007/s11136-021-02902-5. Epub 2021 Jun 22.
7
Medical therapy versus percutaneous coronary intervention in ischemic heart disease: A cost-effectiveness analysis.缺血性心脏病的药物治疗与经皮冠状动脉介入治疗:成本效益分析。
Med J Islam Repub Iran. 2020 Nov 16;34:155. doi: 10.47176/mjiri.34.155. eCollection 2020.
8
Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era?在当代,冠状动脉旁路移植术仍会是患有多支血管病变的老年患者的标准治疗方法吗?
Neth Heart J. 2020 Sep;28(9):457-459. doi: 10.1007/s12471-020-01477-z.
9
A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.一项多中心、随机、双盲、安慰剂对照试验,评估桃仁红花煎颗粒对稳定型冠心病患者的疗效和安全性。
Medicine (Baltimore). 2019 Nov;98(44):e17753. doi: 10.1097/MD.0000000000017753.
10
Invasive strategy in elderly patients with acute coronary syndrome in 2018: close to the truth?2018年老年急性冠状动脉综合征患者的侵入性策略:接近真相了吗?
J Geriatr Cardiol. 2019 Feb;16(2):114-120. doi: 10.11909/j.issn.1671-5411.2019.02.004.